96 results match your criteria: "Clinic of Radiation Oncology[Affiliation]"
Strahlenther Onkol
August 2009
University Clinic of Radiation Oncology, Salzburger Landeskliniken und Paracelsus Medizinische Privatuniversität, Salzburg, Austria.
Background And Purpose: Esophagitis is an important side effect in thoracic radiotherapy, no preventive drug therapy has been established yet. The aim of the present study was to prospectively evaluate the effectiveness of prophylactic antimycotic treatment with amphotericin B lozengers.
Patients And Methods: 40 consecutive patients with high-dose thoracic radiotherapy for lung cancer were investigated in a nonrandomized study.
J BUON
September 2009
Ege University, Faculty of Medicine, Clinic of Radiation Oncology, Izmir, Turkey.
Purpose: The objective of this study was to evaluate the palliation of pain of bone metastases with biphosphonates and different radiotherapy protocols in 372 cancer patients.
Patients And Methods: Patients were treated with one of the 3 different radiotherapy protocols: 30 Gy in 10 fractions (group A), 20 Gy in 5 fractions (group B) and 8 Gy in a single fraction (group C). Two patient groups were studied: one with radiotherapy alone and the second with biphosphonates plus radiotherapy.
J BUON
March 2009
Clinic of Radiation Oncology and Radiology, Institute of Oncology and Radiology of Serbia, Medical Faculty, University of Belgrade, Belgrade, Serbia.
All human beings are exposed to the influence of ionizing radiation from natural, medical and other artificial sources. Therefore, the influence of radiation as a risk factor for cancer development has been among the most studied external factors over the last 6 decades, particularly with respect to radiosensitive tissues and organs. It has been known that female breast tissue is highly sensitive to the carcinogenic effects of radiation, particularly when exposure takes place at younger age.
View Article and Find Full Text PDFStrahlenther Onkol
December 2007
University Clinic of Radiation Oncology, Salzburger Landeskliniken und Paracelsus Medizinische Privatuniversität, Salzburg, Austria.
Radiother Oncol
August 2005
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany.
Background And Purpose: Preclinical and clinical data indicate that high pretherapeutic EGFR expression is associated with poor local tumour control, possibly caused by a high repopulation rate of clonogenic cells during radiotherapy in these tumours. Previous data reported from our laboratory showed a correlation between EGFR expression and acceleration of repopulation in poorly differentiated FaDu human squamous cell carcinoma (SCC) during fractionated irradiation. To test whether this is a general phenomenon, two further SCC were investigated in the present study.
View Article and Find Full Text PDFInt J Radiat Biol
October 2004
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany.
Purpose: To investigate the magnitude and kinetics of repopulation in a moderately well differentiated UT-SCC-14 human squamous cell carcinoma [hSCC] in nude mice. This question is of interest because clinical data indicate a higher repopulation capacity in those SCC that have preserved characteristics of differentiation, which appears to be in contrast to results on FaDu and GL hSCC previously reported from this laboratory.
Methods And Materials: UT-SCC-14 tumours were transplanted subcutaneously into the right hind leg of NMRI nu/nu mice.
Radiother Oncol
March 2005
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Fetscherstr. 74, 01307 Dresden, Germany.
Background And Purpose: The present study addresses whether recovery of sublethal damage in tumours may change during fractionated irradiation in FaDu human squamous cell carcinoma and whether such an effect might contribute to the pronounced time factor of fractionated irradiation previously found in this tumour.
Patients And Methods: FaDu tumours were transplanted s.c.
Int J Radiat Biol
July 2003
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany.
Purpose: To investigate the effect of BIBX1382BS, an inhibitor of the epidermal growth factor receptor tyrosine kinase, on proliferation and clonogenic cell survival of FaDu human squamous cell carcinoma in vitro, and on tumour growth and local tumour control after fractionated irradiation over 6 weeks in nude mice. FaDu human squamous cell carcinoma is epidermal growth factor receptor positive and significant repopulation during fractionated irradiation was demonstrated in previous experiments.
Materials And Methods: Receptor status, receptor phosphorylation, cell cycle distribution, cell proliferation and clonogenic cell survival after irradiation were assayed with and without BIBX1382BS (5 microM) in vitro.
Int J Radiat Biol
July 2003
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany.
Purpose: To determine the impact of increased necrotic cell loss on the repopulation rate of clonogenic cells during fractionated irradiation in human FaDu squamous cell carcinoma in nude mice.
Materials And Methods: FaDu tumours were transplanted into pre-irradiated subcutaneous tissues. This manoeuvre has previously been shown to result in a clear-cut tumour bed effect, i.
Int J Radiat Biol
July 2003
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Purpose: Previous functional radiobiological experiments demonstrated a significant acceleration of repopulation after 3 weeks and reoxygenation after 12 days of radiotherapy of FaDu tumours. Owing to the temporal coincidence between repopulation and reoxygenation, it was hypothesized that the improved oxygenation status during fractionated irradiation might be the preceding stimulus for increased proliferation. The study investigated whether these changes in repopulation and re-oxygenation are reflected by histological parameters of proliferation and the tumour micromilieu.
View Article and Find Full Text PDFCurr Med Chem Anticancer Agents
September 2003
Clinic of Radiation Oncology, University Hospital Dresden, Germany.
The development of new chemotherapeutic agents and concepts of radiation therapy has led to new perspectives in cancer therapy. Recently developed novel agents interfere with molecular mechanisms that are altered in cancer cells. Cyclooxygenase-2 (COX-2) is an enzyme induced by a variety of factors including tumor promoters, cytokines, growth factors and hypoxia.
View Article and Find Full Text PDFInt J Radiat Biol
December 2001
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
Purpose: To investigate the impact of the tumour bed effect (TBE) on histological parameters of the micromilieu, radiobiological hypoxic fraction and local control after fractionated irradiation in FaDu squamous-cell carcinoma in the nude mouse. This tumour has previously shown a clear-cut TBE caused by increased necrotic cell loss at a constant cell production rate in the viable tumour compartment.
Materials And Methods: Human FaDu tumours were studied in the NMRI nude mouse.
Int J Radiat Oncol Biol Phys
October 2001
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
Purpose: FaDu human squamous cell carcinoma (FaDu-hSCC) showed a clear-cut time factor during fractionated radiotherapy (RT) under ambient blood flow. It remained unclear whether this is caused solely by proliferation or if radioresistance resulting from increasing hypoxia contributed to this phenomenon. To address this question, repopulation of clonogenic FaDu cells during fractionated RT under clamp hypoxia was determined by local tumor control assays, and compared to the results after irradiation with the same regimen under ambient blood flow.
View Article and Find Full Text PDFActa Oncol
September 2001
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Very little is known about the correlation between the radiobiological hypoxic fraction (rHF) and other measures of tumour oxygenation during fractionated irradiation. In the present study the rHF is determined in untreated human FaDu and GL squamous cell carcinoma in nude mice and in tumours irradiated with 10 fractions in 2 weeks and 20 fractions in 4 weeks, using tumour control as the experimental endpoint. The results were compared with measurements of the pO2, the interstitial fluid pressure (IFP) and the relative viable tumour area.
View Article and Find Full Text PDFRadiother Oncol
May 2001
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
Background And Purpose: To study whether the magnitude of the time factor is different for continuously fractionated irradiation and for fractionation protocols including gaps.
Materials And Methods: Two human head and neck squamous cell carcinomas (SCCs), FaDu and GL, were transplanted subcutaneously into the right hindleg of NMRI (nu/nu) mice and irradiated with 30 fractions under ambient conditions within 2, 6 and 10 weeks. Irradiations within 6 and 10 weeks were given either as a continuous course or with a mid-course gap of 3 weeks.
Int J Radiat Biol
October 2000
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Purpose: To compare the effect of fractionated irradiation with increasing, constant or decreasing weekly dose intensity on local tumour control.
Materials And Methods: Human squamous cell carcinomas, FaDu and GL, were grown in nude mice. Thirty fractions were applied under ambient conditions with increasing, constant or decreasing weekly dose intensity within a constant overall treatment time of 6 weeks.
Radiother Oncol
January 1999
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Background And Purpose: The impact of overall treatment time of fractionated irradiation on local control of slow growing human GL squamous cell carcinoma (SCC) was determined.
Materials And Methods: Moderately well differentiated and keratinizing human GL SCC with a volume doubling time of 8 days were transplanted subcutaneously into the right hindleg of NMRI (nu/nu) mice and irradiated with 30 fractions under ambient conditions over 2, 3, 4.5, 6 and 10 weeks.
Int J Radiat Oncol Biol Phys
January 1999
Clinic of Radiation Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice, Poland.
Purpose: Radiation therapy is the treatment of choice for early glottic squamous cell cancer in many institutions over the world. Despite a relatively homogenous clinical model of T1 glottic tumors for the fractionation studies, the relationships between dose-time parameters remain unclear. To analyze the influence of fractionation parameters and hemoglobin level on tumor cure, this study has been performed.
View Article and Find Full Text PDFRadiother Oncol
February 1998
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Hyperfractionated radiation therapy (HF) is one of the most promising modifications of conventional fractionation (CF). However, two recent reviews on the efficacy of HF reached opposite conclusions: Stuschke and Thames (Int. J.
View Article and Find Full Text PDFInt J Radiat Biol
February 1998
Clinic of Radiation Oncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Germany.
Purpose: To compare values for the alpha/beta ratio in experimental tumours irradiated either under conditions of clamping and short overall time or under more 'clinically realistic' conditions.
Materials And Methods: Human squamous cell carcinomas, FaDu and GL, were grown in nude mice. Alpha/beta values were determined from local tumour control data after treatment with single doses and 2, 4, and 8 fractions under clamp hypoxia in 3.
Strahlenther Onkol
May 1989
Clinic of Radiation Oncology, University of Düsseldorf, FRG.